Please Wait.....
Report
Europe Lung Cancer Screening Market Forecast to 2030 - Regional Analysis - by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)
Market Report I 2023-11-01 I 131 Pages I The Insight Partners
The Europe lung cancer screening market is expected to grow from US$ 593.25 million in 2022 to US$ 1,090.99 million by 2030. It is estimated to grow at a CAGR of 7.9% from 2022 to 2030.
Rising Lung Cancer Incidences Fuel Europe lung cancer screening market.
Lung cancer is among one of the main causes of mortality across the world. Lung cancer screening is a critical component of cancer prevention approaches. The prognosis of lung cancer patients is better when the disease is diagnosed early, so people at high risk of lung cancer are prompted to undergo routine checkups to detect the formation of cancerous growth in their lungs.
As per research conducted by the cancer journal Annals of Oncology, around 1,261,990 cancer patients are expected to die in 2023 in the EU region. Lung cancer death rates would increase by over 1% to 13.6 per 100,000. As more UK women started smoking earlier than those in the EU, there will be a 13.8% decrease in the death rate from lung cancer among women in the UK, although the death rate of 16.2 per 100,000 is still higher than among women in the EU. In the UK, lung cancer currently claims more per 100,000 than breast cancer, which claims 13.5 per 100,000.
When the researchers particularly examined lung cancer death rates in five EU nations in addition to the UK, they discovered that while rates are expected to decline for men in the most populous six nations (France, Germany, Italy, Poland, and Spain), they will increase for women in France, Italy, and Spain by about 14%, 5.6%, and 5%, respectively. The researchers discovered that among women in various age groups, expected mortality rates from lung cancer decreased among those between the ages of 25 and 64 but increased among those between the ages of 65 and over 75, leading to an increase overall. Also, according to the National Center for Biotechnology Information (NCBI), each year, ~41,000 new diagnoses of lung cancers and 34,000 deaths are recorded in Italy. Thus, the rising incidence of lung cancer worldwide is contributing to the initiation of lung cancer screening programs, which is, in turn, driving the market growth.
Europe Lung Cancer Screening Market Overview
The Europe lung cancer screening market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The regional growth is attributed to various factors, such as the increasing incidence of lung cancer and awareness of side lung cancer screening and diagnosis among people. Also, rising government support for screening has led to the further growth of the market.
The increasing prevalence of lung cancer has made its screening extremely important for early detection. Lung cancer screening is suggested for older adults who are long-time smokers and do not have any symptoms related to lung cancer. Physicians use a low-dose computerized tomography (LDCT) scan or X-ray for screening.
According to an article titled "Lung Cancer in Germany," published in the Journal of Thoracic Oncology, in June 2022, cancer is among the second most frequent cause of death in Germany, accounting for 25% of all deaths. In men, lung cancer ranks second after cardiovascular disease, accounting for 6.5% of all-cause mortality. With an age-standardized incidence rate of 52.1 and 32.7 and (per 100,000) in men and women, respectively, lung cancer ranks second in men and third in women (accounting for 13.3% and 9.4% of all newly diagnosed cancers, respectively). The average age of cancer diagnosis is 70 years (men) and 69 years (women); 52% of all patients present with stage IV. The incidence rates in women and men have converged since the 1990s because of long-term changes in smoking habits. Currently, every fourth man (27.0%) and every fifth woman (20.8%) in Germany smokes regularly
Europe Lung Cancer Screening Market Revenue and Forecast to 2030 (US$ Million)
Europe Lung Cancer Screening Market Segmentation
The Europe lung cancer screening market is segmented into cancer type, technology, age group, end user, and country.
Based on cancer type, the Europe lung cancer screening market is segmented into non-small cell lung cancer (NSCLC), and small cell lung cancer. The non-small cell lung cancer (NSCLC) segment held a larger share of the Europe lung cancer screening market in 2022.
Based on technology, the Europe lung cancer screening market is segmented into chest X-ray, low dose computed tomography (LDCT), liquid biopsy, and others. Low dose computed tomography (LDCT) segment held the largest share of the Europe lung cancer screening market in 2022.
Based on age group, the Europe lung cancer screening market is segmented into 50 and older, and below 50. 50 and older segment held the larger share of the Europe lung cancer screening market in 2022.
Based on end user, the Europe lung cancer screening market is segmented into hospital, diagnostic centre, and others. Hospital segment held the largest share of the Europe lung cancer screening market in 2022.
Based on country, the Europe lung cancer screening market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe lung cancer screening market in 2022.
Siemens AG, Koninklijke Philips NV, Canon Inc, Medtronic, GE HealthCare, Nuance Communications Inc, and Intelerad Medical Systems are some of the leading companies operating in the Europe lung cancer screening market.
Table of Contents
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Lung Cancer Screening Market - by Technology
1.3.2 Europe Lung Cancer Screening Market - by Cancer Type
1.3.3 Europe Lung Cancer Screening Market - by Age Group
1.3.4 Europe Lung Cancer Screening Market - by End User
1.3.5 Europe Lung Cancer Screening Market - by Country
2. Europe Lung Cancer Screening Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Lung Cancer Screening Market - Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert's Opinion
5. Europe Lung Cancer Screening Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Lung Cancer Incidences
5.2 Market Restraints
5.2.1 High Cost of Lung Cancer Screening Tests
5.3 Market Opportunities
5.3.1 Structured Lung Cancer Screening Program
5.4 Future Trends
5.4.1 Mobile Lung Cancer Screening Truck
5.5 Impact Analysis
6. Europe Lung Cancer Screening Market - Europe Analysis
6.1 Europe Lung Cancer Screening Market Revenue Forecast and Analysis
7. Europe Lung Cancer Screening Market - Revenue and Forecast to 2028 - By Cancer Type
7.1 Overview
7.2 Europe Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non-Small Cell Lung Cancer (NSCLC)
7.3.1 Overview
7.3.2 Non-Small Cell Lung Cancer (NSCLC): Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
7.4.1 Overview
7.4.2 Small Cell Lung Cancer: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Lung Cancer Screening Market Analysis - by Technology
8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
8.2.1 Overview
8.2.2 Low-Dose Computed Tomography (LDCT): Europe Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
8.3.1 Overview
8.3.2 Chest X-ray: Europe Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
8.4.1 Overview
8.4.2 Liquid Biopsy: Europe Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
9. Europe Lung Cancer Screening Market Analysis - by Age Group
9.1 Overview
9.2 & Older
9.2.1 Overview
9.2.2 & Older: Australia Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
9.3.1 Overview
9.3.2 Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Lung Cancer Screening Market Analysis - by End User
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
11. Europe Lung Cancer Screening Market - Revenue and Forecast to 2028 - Country Analysis
11.1 Europe: Europe Lung Cancer Screening Market Overview
11.1.1.1 Germany: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 Germany: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.3 Germany: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.1.4 Germany: Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.5 Germany: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.1.6 Germany: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 UK: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 UK: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.3 UK: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.2.4 UK: Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.5 UK: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.2.6 UK: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 France: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 France: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.3 France: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.3.4 France: Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.5 France: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.3.6 France: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 Italy: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.3 Italy: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.4.4 Italy: Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.5 Italy: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.4.6 Italy: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.5 Spain: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.3 Spain: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.5.4 Spain: Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.5 Spain: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.5.6 Spain: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.6 Rest of Europe: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.3 Rest of Europe: Europe Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.6.4 Rest of Europe: Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.5 Rest of Europe: Europe Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.6.6 Rest of Europe: Europe Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
12. Europe Lung Cancer Screening Market-Industry Landscape
12.1 Recent Growth Strategies
12.1.1 Overview
13. Company Profiles
13.1 Intelerad Medical Systems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Nuance Communications Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE HealthCare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Medtronic
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Canon Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Koninklijke Philips NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Siemens AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
List of Tables
Table 1. Germany Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 2. Germany Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 6. UK Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 7. UK Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 8. UK Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. France Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 10. France Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 11. France Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 12. France Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Italy Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 14. Italy Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. Spain Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 18. Spain Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Europe Lung Cancer Screening Market, by Cancer Type - Revenue and Forecast to 20228 (US$ Million)
Table 22. Rest of Europe Lung Cancer Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe Lung Cancer Screening Market, by Age Group - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe Lung Cancer Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. Recent Growth Strategies in the Europe Lung Cancer Screening Market
Table 26. Glossary of Terms
List of Figures
Figure 1. Europe Lung Cancer Screening Market Segmentation
Figure 2. Europe Lung Cancer Screening Market, by Country
Figure 3. Europe Lung Cancer Screening Market Overview
Figure 4. Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Europe Lung Cancer Screening Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. Europe Lung Cancer Screening Market Impact Analysis of Driver and Restraints
Figure 9. Europe Lung Cancer Screening Market - Revenue Forecast and Analysis - 2020-2030
Figure 10. Europe Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
Figure 11. Non-Small Cell Lung Cancer (NSCLC): Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Small Cell Lung Cancer: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 14. Low-Dose Computed Tomography (LDCT): Europe Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 15. Chest X-ray: Europe Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 16. Liquid Biopsy: Europe Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Europe Lung Cancer Screening Market- Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 19. & Older: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Below 50: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Europe Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 22. Hospitals: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Diagnostic Centers: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Lung Cancer Screenings Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe Lung Cancer Screening Market, by Key Country - Revenue (2022) (US$ Million)
Figure 26. Europe Lung Cancer Screening Market Revenue Share, by Country, (2022 & 2030)
Figure 27. Germany: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. UK: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. France: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Italy: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Spain: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Rest of Europe: Europe Lung Cancer Screening Market - Revenue and Forecast to 2030 (US$ Million)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security